Ocuphire Pharma, Inc. Profile Avatar - Palmy Investing

Ocuphire Pharma, Inc.

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily prese…

Biotechnology
US, Farmington Hills [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Ocuphire Pharma, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Ocuphire Pharma, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Ocuphire Pharma, Inc..

End of OCUP's Analysis
CIK: 1228627 CUSIP: 67577R102 LEI: - UEI: -
Secondary Listings
OCUP has no secondary listings inside our databases.